These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 9683215)

  • 1. Severe cutaneous reaction due to terazosin.
    Hernández-Cano N; Herranz P; Lázaro TE; Mayor M; Casado M
    Lancet; 1998 Jul; 352(9123):202-3. PubMed ID: 9683215
    [No Abstract]   [Full Text] [Related]  

  • 2. Lichenoid drug eruption to terazosin.
    Koh MJ; Seah PP; Tay YK; Mancer K
    Br J Dermatol; 2008 Feb; 158(2):426-7. PubMed ID: 18047505
    [No Abstract]   [Full Text] [Related]  

  • 3. Terazosin for benign prostatic hyperplasia.
    Med Lett Drugs Ther; 1994 Feb; 36(916):15-6. PubMed ID: 7508075
    [No Abstract]   [Full Text] [Related]  

  • 4. [The use of terazosin hydrochloride (Hytrin) in the treatment of patients with benign prostatic hyperplasia].
    Sivkov AV; Apolikhin OI; Medvedev AA
    Urol Nefrol (Mosk); 1997; (5):50-3. PubMed ID: 9412019
    [No Abstract]   [Full Text] [Related]  

  • 5. [Terazosin].
    Schäfers RF; Michel MC
    Dtsch Med Wochenschr; 1998 Apr; 123(15):459-60. PubMed ID: 9581161
    [No Abstract]   [Full Text] [Related]  

  • 6. [Terazosin in the treatment of benign prostatic hypertrophy].
    Andres M; De Cobelli O; Carmignani L; Musci R; Kocjancic E; Panizzutti M; Rocco F
    Arch Ital Urol Androl; 1995 Feb; 67(1):37-9. PubMed ID: 7538386
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The efficacy of terazosin, finasteride, or both in benign prostatic hyperplasia. Veterans Affairs Cooperative Studies Benign Prostatic Hyperplasia Study Group.
    Lepor H; Williford WO; Barry MJ; Brawer MK; Dixon CM; Gormley G; Haakenson C; Machi M; Narayan P; Padley RJ
    N Engl J Med; 1996 Aug; 335(8):533-9. PubMed ID: 8684407
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Terazosin, finasteride, or both in benign prostatic hyperplasia.
    Thien T; Lenders JW
    N Engl J Med; 1997 Jan; 336(4):294. PubMed ID: 9005318
    [No Abstract]   [Full Text] [Related]  

  • 9. The safety and efficacy of terazosin for the treatment of benign prostatic hyperplasia.
    Lepor H; Knapp-Maloney G; Wozniak-Petrofsky J
    Int J Clin Pharmacol Ther Toxicol; 1989 Aug; 27(8):392-7. PubMed ID: 2477339
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Terazosine in the treatment of benign prostatic hypertrophy].
    Caine M
    J Urol (Paris); 1993; 99(6):311-3. PubMed ID: 7516376
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intraoperative floppy iris syndrome associated with terazosin.
    Venkatesh R; Veena K; Gupta S; Ravindran RD
    Indian J Ophthalmol; 2007; 55(5):395-6. PubMed ID: 17699957
    [No Abstract]   [Full Text] [Related]  

  • 12. Terazosin now indicated for benign prostatic hyperplasia.
    Am J Hosp Pharm; 1994 Jan; 51(1):25. PubMed ID: 7510930
    [No Abstract]   [Full Text] [Related]  

  • 13. Terazosin, finasteride, or both in benign prostatic hyperplasia.
    Kuchel GA; DuBeau CE; Resnick NM
    N Engl J Med; 1997 Jan; 336(4):293-4; author reply 294. PubMed ID: 9005317
    [No Abstract]   [Full Text] [Related]  

  • 14. [New in Austria approved specialty drugs and new knowledge regarding currently available specialty drugs. Uroflo].
    Wien Klin Wochenschr; 1995; 107(15):472-6. PubMed ID: 7545857
    [No Abstract]   [Full Text] [Related]  

  • 15. Side effects of terazosin in the treatment of symptomatic benign prostatic hyperplasia.
    McKiernan JM; Lowe FC
    South Med J; 1997 May; 90(5):509-13. PubMed ID: 9160069
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical comparison of selective and non-selective alpha 1A-adrenoceptor antagonists for bladder outlet obstruction associated with benign prostatic hyperplasia: studies on tamsulosin and terazosin in Chinese patients. The Chinese Tamsulosin Study Group.
    Na YJ; Guo YL; Gu FL
    J Med; 1998; 29(5-6):289-304. PubMed ID: 10503165
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The medication minute: terazosin.
    Bartek JK; McNamee M
    Urol Nurs; 1995 Jun; 15(2):67-8. PubMed ID: 7541161
    [No Abstract]   [Full Text] [Related]  

  • 18. [Therapy of benign prostatic hyperplasia: terazosin or finasteride?].
    Trinkler FB
    Praxis (Bern 1994); 1997 Aug; 86(34):1305-6. PubMed ID: 9381019
    [No Abstract]   [Full Text] [Related]  

  • 19. A multicenter, randomized, double-blind, placebo-controlled study to evaluate the safety and efficacy of terazosin in the treatment of benign prostatic hyperplasia.
    Elhilali MM; Ramsey EW; Barkin J; Casey RW; Boake RC; Beland G; Fradet Y; Trachtenberg J; Orovan WL; Schick E; Klotz LH
    Urology; 1996 Mar; 47(3):335-42. PubMed ID: 8633398
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Terazosin for BPH.
    Jerant AF
    J Fam Pract; 1995 Mar; 40(3):222-3. PubMed ID: 7533204
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.